Enjoyment of Infant Formulas Based on Cow or Goat Milk Protein (CHARLIE)

December 23, 2021 updated by: Centre Hospitalier Intercommunal Creteil
To assess parental perceptions on infant feeding behavior and enjoyment with a goat milk formula compared to a cow milk formula

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

This is a feasibility study to determine the utility of two new standardized psychometric tools for paediatricians to assess and manage feeding difficulties in formula fed infants. Baby Eating Behaviour Questionnaire (BEBQ) and Montreal Children's Hospital Feeding Scale (MCH-Feeding Scale) will be used in this study.

The secondary objectives are to determine if these tools can then measure the changes in behaviour after introducing two formula that differ in the sources of protein, ie formula made from whole goat milk compared to a conventional formula made from cow milk proteins. The quality of life and general health outcomes of these infants will also be monitored.

Study Type

Interventional

Enrollment (Actual)

73

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Beausoleil, France, 06240
        • 2 Avenue Camille Blanc,
      • Chatou, France, 78400
        • 20 avenue du général Sarail
      • Le Blanc-Mesnil, France, 93150
        • 65 Avenue Henri Barbusse,
      • Les Lilas, France, 93260
        • 53 Boulevard De La Liberté
      • Levallois-Perret, France, 92300
        • 41 Rue Aristide Briand,
      • Maisons-Alfort, France, 94700
        • 157 Avenue du Général Leclerc
      • Neuilly-sur-Seine, France, 92200
        • 169 Avenue Achille Peretti
      • Paris, France, 75019
        • CHU Robert Debré, 48 Bd Sérurier
      • Paris, France, 75005
        • 4 Rue Edouard Quenu
      • Paris, France, 75009
        • 67 Rue Condorcet,
      • Paris, France, 75009
        • 67 Rue Condorcet
      • Paris, France, 75011
        • 92 Avenue de la République
      • Suresnes, France, 92150
        • 3 Allée du 8 Mai 1945,
      • Vincennes, France, 94300
        • 13 Villa Beauséjour

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

2 months to 3 months (CHILD)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy infants aged 2-3 months, predominantly formula fed

Exclusion Criteria:

  • Infants born less than 37GA
  • Confirmed or suspected cow milk protein allergy
  • Predominantly breast fed
  • Infants suffering from chronic disease

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: OTHER
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: DOUBLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: CMF
infant formula based on cow milk protein fractions
Taking a infant formula based on cow milk protein fractions, 4-5 feeds per day given by bottle, 180-210 ml/feed, total 800-900ml per day for one mounth
EXPERIMENTAL: GMF
infant formula based on whole goat milk
Taking a infant formula based on whole goat milk, 4-5 feeds per day given by bottle, 180-210 ml/feed, total 800-900ml per day for one mounth

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feeding enjoyment score from Baby Eating Behaviour Questionnaire (BEBQ).
Time Frame: 1 month
Feeding enjoyment score from Baby Eating Behaviour Questionnaire (BEBQ).
1 month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Feeding behaviour assessed by Montreal Children's Hospital Feeding Scale
Time Frame: 1 month
This feeding scale permit to distinguish babies with no feeding difficulties (score under 61) or with mild (61-65) , moderate (65-70), or severe feeding disorders (>70)
1 month
Quality of life assessed by QUALIN
Time Frame: 1 month
Quality of life assessed by QUALIN
1 month
Formula liking, using 4-point visual analog scale (VAS)
Time Frame: 1 month
Formula liking, using 4-point visual analog scale (VAS). The range of this scale goes from 0 (my baby hates this fomula) to 10 (my baby loves this formula)
1 month
Incidences of rash
Time Frame: 1 month
Incidences of rash
1 month
Incidences of dry skin
Time Frame: 1 month
Incidences of dry skin
1 month
Incidences of eczema
Time Frame: 1 month
Incidences of eczema
1 month
Gastrointestinal symptoms
Time Frame: 1 month
Gastrointestinal symptoms
1 month
Weight
Time Frame: 1 month
1 month
Height
Time Frame: 1 month
1 month
head circomference
Time Frame: 1 month
1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

June 1, 2018

Primary Completion (ACTUAL)

December 5, 2021

Study Completion (ACTUAL)

December 5, 2021

Study Registration Dates

First Submitted

March 28, 2018

First Submitted That Met QC Criteria

April 4, 2018

First Posted (ACTUAL)

April 5, 2018

Study Record Updates

Last Update Posted (ACTUAL)

December 27, 2021

Last Update Submitted That Met QC Criteria

December 23, 2021

Last Verified

December 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • CHARLIE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Feeding Behavior

Clinical Trials on CMF

3
Subscribe